You are here: Industry Insights > COVID-19

News List

Novavax Awarded $1.6B from Operation Warp Speed contractpharma
July 08, 2020
Supports late-stage clinical development, large-scale manufacturing of NVX-CoV2373, including production of 100 million doses starting in late 2020.
University of Oxford Selects Axiom eClinical Suite for Clinical Trial contractpharma
July 08, 2020
?Axiom Real-Time Metrics, a provider of unified eClinical solutions and services, has announced its engagement with the University of Oxford for its large-scale clinical trial focused on COVID-19 preventative treatments.
SGS Initiates Trial of Potential COVID-19 Treatment contractpharma
July 08, 2020
Will evaluate Biophytis’ Sarconeos (BIO101) by looking at safety and tolerability and improvements to respiratory function.
7 Hills Announces Positive Data On 7HP349 contractpharma
July 08, 2020
Studies show the small molecule adjuvant increases IgG binding antibody responses.
In Fight Against COVID-19, CSL Behring Begins Trial to Evaluate Monoclonal Antibody (CSL312) for Respiratory Distress prnewswire
July 07, 2020
Global biotherapeutics leader CSL Behring announced that the first patient has been enrolled in its Phase 2 study to assess the safety and efficacy of CSL312 (garadacimab, Factor XIIa antagonist monoclonal antibody) to treat patients suffering from ...
Assured Bio Labs Receives AIHA Accreditation for COVID-19 Environmental Testing prnewswire
July 07, 2020
An environmental microbiology lab in Oak Ridge is the first U.S. lab to receive accreditation for surface and air analysis of the virus that causes COVID-19.
COVID-19 Panic Spikes Global Demand for Injectable Benzodiazepine: Future Market Insights Study prnewswire
July 07, 2020
Future Market Insight's projections reveal that the global injectable benzodiazepine market is set to shoot up significantly in 2020, reaching a value of US$ 260 Mn in the wake of the coronavirus pandemic.
NHS launches ‘Your COVID Recovery’ service pharmatimes
July 07, 2020
The NHS has launched a new on-demand service for tens of thousands of people suffering from the long-term effects of coronavirus.
King's researchers win ￡1m grant for COVID-19 research pharmatimes
July 07, 2020
A research team at King's College London led by Professor Michael Malim from the School of Immunology & Microbial Sciences has been awarded ￡1 million funding for research into COVID-19.
UK study to research long-term health impact of COVID-19 pharmatimes
July 07, 2020
The UK government has announced the launch of “one of the world’s largest comprehensive research studies” into the long-term health impacts of coronavirus on hospitalised patients.